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Abstract
Congenital Heart Disease (CHD) is one of the most common birth defects. Elucidating the molecular mechanisms underlying
normal cardiac development is an important step towards early identification of abnormalities during the developmental
program and towards the creation of early intervention strategies. We developed a novel computational strategy for
leveraging high-content data sets, including a large selection of microarray data associated with mouse cardiac
development, mouse genome sequence, ChIP-seq data of selected mouse transcription factors and Y2H data of mouse
protein-protein interactions, to infer the active transcriptional regulatory network of mouse cardiac development. We
identified phase-specific expression activity for 765 overlapping gene co-expression modules that were defined for obtained
cardiac lineage microarray data. For each co-expression module, we identified the phase of cardiac development where
gene expression for that module was higher than other phases. Co-expression modules were found to be consistent with
biological pathway knowledge in Wikipathways, and met expectations for enrichment of pathways involved in heart lineage
development. Over 359,000 transcription factor-target relationships were inferred by analyzing the promoter sequences
within each gene module for overrepresentation against the JASPAR database of Transcription Factor Binding Site (TFBS)
motifs. The provisional regulatory network will provide a framework of studying the genetic basis of CHD.
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Introduction
Congenital heart disease (CHD) has been reported to occur in 5
to 8 per 1,000 live births [1]. Due to its pathological severity, CHD
has become an important public health issue as a leading cause of
infant mortality. According to a clinical report on the infant
mortality resulting from CHD in the US [2,3], up until 2006, the
infant mortality rate due to CHD decreased but was still as high as
37.69 per 100,000 live births. In addition to the high infant
mortality rate, up to half of the surviving children will have the
impaired neurodevelopmental outcomes across a wide spectrum of
domains [1]. Other than cases of syndromic CHD, It is also
believed that for fetuses with CHD, hypoxemia from the
intracardiac mixing of blood can cause cerebral hypoxia, and
inadequate fetal cerebral oxygen delivery thus results in impaired
cerebral development [1]. It is thus crucial to understand the
mechanisms of cardiac development to be able to elucidate the
mechanisms of pathogenesis in CHD for improving diagnostic
approaches and therapeutic strategies.
Several recent studies have focused on cardiac developmental
genetics with the aim of identifying the genetic basis of congenital
heart disease [4] (Table S1)[5]. Multiple transcription factor
genes with defined functions in mouse cardiac development have
been identified [6] (Table 1). To complement knowledge of the
required normal gene functions during cardiac development,
investigators are digging deeper into the mechanisms correspond-
ing to these gene functions by uncovering the molecular
interactions that define developmental pathways. Some of the
most important interactions to consider include protein-DNA
interactions, protein-protein interactions and genetic interactions
(genetic associations without a clearly defined molecular mecha-
nism). Figure 1 gives an example of a molecular interaction
network comprising several genes that are important in mouse
cardiac development. This interaction network graph was
generated using Cognoscente, which provides a knowledge base
of biomolecular interactions supported by the literature [7].
Figure 1 illustrates an example of complex transcriptional
regulation during mouse cardiac development, where the Foxh1
transcription factor physically and functionally interacts with the
Nkx2-5 transcription factor to combinatorially regulate transcrip-
tion of the Mef2c gene, while the Mef2c protein product is also a
known transcription factor that directly regulates the transcription
of the Calreticulin gene and the BOP gene (not shown in this
graph) [8–10]. Therefore, for a comprehensive understanding of
cardiac development, elucidation of the transcriptional signal
propagation between transcription factors (TFs) or between TFs
and their non-TF targets in the genomic scope is one of the highest
priorities (see examples of the transcriptional signal propagation in
Figure S1, which summarizes the literature-based mouse
transcriptional interactions from the public version of the
TRANSFAC database [11,12]). This knowledge is conveyed in
the structure of a Transcriptional Regulatory Network (TRN). A
TRN is the collection of connected transcriptional interactions
involved in transcription-level regulation of a developmental
process, homeostatic process, or disease process. Representations
of TRNs by Cognoscente contain hypernodes which may
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correspond to genes or their corresponding products (e.g. protein),
while edges with a red arrow pointing from the TF to its target
gene represent a physical interaction between the TF protein and
their target genes. One possible role for protein-protein interac-
tions is combinatorial regulation by TFs of a specific target.
Deciphering the details of underlying TRNs is a major goal of
modern research in cardiac development, and will result in an
important resource for genetic counseling and for developing more
effective treatment plans for congenital heart disease.
Sea urchin and Drosophila have been two of the most useful
models for studying TRNs [13,14]. Investigators have traditionally
defined developmental TRNs by assembling knowledge of
transcriptional regulation member molecules from individual
experiments into a network structure. This laborious approach
to elucidating TRNs from respective experiments of single (or
several) transcriptional regulation(s) produces reliable biological
information. However, elucidating the complete networks in more
complex organisms, such as human or mouse, would be extremely
difficult using this strategy, as much time and labor are required to
characterize the role of just one gene in a physiological or
pathological state. The strategy described above is the bottom-up
approach of network construction. Computational strategies offer
a top-down approach to network construction in the genome-wide
scope that complements the bottom-up approach. In the wake of
biotechnology advancements, high-content experimental data is
fueling this top-down research to foster TRN reconstruction in the
genome-wide scope using computational strategies. Previous
studies have applied the top-down approach on high-content
experimental data to examine the cardiac TRN comprised of
several key TFs [15], and to infer spatio-temporal protein
networks active in human heart development [16].
There are several popular computational strategies for inferring
TRNs, including Boolean networks, Bayesian networks, systems of
differential equations, genome-wide pairwise correlation and
genome-wide pairwise Mutual Information [17]. However, each
of them has certain drawbacks. The Boolean algorithm assigns
each variable a binomial value, which could omit important
information about multinomial/continuous variables. Bayesian
network construction is very promising for representing and
inferring causal relationships, but this strategy is only effective for
the construction of small TRNs, due to the super-exponential
increase in algorithm running time for large networks. Defining a
differential equation model of a TRN requires knowing the
equation of dynamics, then calculating the parameters to optimize
the TRN model against real data. However, deriving an
appropriate equation of dynamics remains as a challenge.
Furthermore, solving a differential equation system of any realistic
complexity presents a challenge. As to the correlation and mutual
information algorithms, manually setting the appropriate thresh-
olds without a principled reference poses difficulties in most cases.
Strategies applying algorithms with these drawbacks are thus not
satisfying. In recent decades, a large amount of experimental
information about biological networks has been collected, and
opportunities have thus increased for deciphering their topological
features, including defining their identity as scale-free networks,
small world networks, adaptive motifs, feed-back motifs, ‘AND’
and ‘OR’ logic motifs and modular networks (Klipp, E. et al.
2009). This motivates a systematic effort of determining network
topological features, which will benefit the effectiveness and utility
of network reconstruction. High modularity is one of the most
accepted network topological features of TRNs [18,19]. Modu-
larity is a measure of the structure of networks, where networks
with high modularity have dense connectivity between nodes
within defined modules (or groups), and relatively sparser
connectivity between nodes from different modules.
Based on the modularity feature of TRNs, we first describe a
novel computational strategy for inferring the TRN of mouse
cardiac development in the genomic scope. We developed an
approach of comprehensive clustering to retrieve the optimal set of
co-expression gene modules by analyzing the transcriptomic data
associated with mouse cardiac development. We defined the
optimal set of modules using the Davis-Bouldin Index (see
RESULTS). We then identified modules with phase specific
expression activity in the phases of mouse cardiac development.
Next we applied an alignment strategy that identifies the putative
transcription factor binding sites (TFBS) along gene promoter
sequences of every selected module, and determined overrepre-
sented TFBS(s) whose corresponding TF(s) may initialize co-
expression in the module via co-regulation. Overrepresented
pathways represented in each module were also annotated. We
created a graphic representation of inferred transcriptional
regulations to visualize the provisional reconstruction of the
TRN for mouse cardiac development (The transcriptional
regulations were represented in the graph as TFs with arrows
pointing to their corresponding targets). Finally, we applied the
source data of sampled TF genomic binding sites from the
ENCODE database to evaluate the provisional transcriptional
regulations from our analysis. Taken together, we have established
the novel computational strategy for inferring the TRN in mouse
cardiac development that advances a provisional gene regulatory
atlas.
Results
Retrieving the optimal set of co-expression gene
modules corresponding to the minimal Davies-Bouldin
Index
Modularity provides a control structure for silencing or
activating discrete parts of a network. Modularity of a biological
network thus provides a selection advantage that appears to have
been conserved through evolution [20]. Modularity of TRNs
follows this tendency to be well conserved in the complex
organisms, such as human and mouse [21–24]. In biological
networks, modules can be understood in terms of subsystems. The
modularity of TRNs can be represented by co-expression gene
modules inside each of which the modular genes are expressed
covariantly across a large collection of expression sets of different
samples [18,19]. Here we leveraged mouse as a model to study the
TRN of cardiac development with our computational strategy
based on the modularity feature of co-expression. We used
publicly available microarray data from the Gene Expression
Ominbus (GEO), from which we collected transcriptomic data
from 239 selected microarray experiments (arrays) as our source
data (see MATERIALS AND METHODS). These experiments
are all based on mouse heart tissues or mouse embryonic stem cells
(i.e. heart lineage samples).
By leveraging the modularity feature of TRNs, we have the
opportunity to infer TRNs when the co-expression gene modules
are properly retrieved. Module structure implies the coordination
of TFs responsible for the co-expression in such modules.
Clustering, a type of unsupervised machine learning, is the routine
approach used to identify co-expression gene modules from
transcriptomic data [25]. However, due to the non-overlapping
design of standard clustering algorithms, each gene is assigned
membership to only one specific co-expression gene module. This
is not likely to accurately represent biological circuits, where a
gene may have multiple TF regulatory binding sites on the
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promoter and may thus be the member of multiple co-expression
gene modules [18]. Moreover, modular overlap has been revealed
in many biological network systems [26,27]. Therefore, some
genes have multiple modular memberships of co-expression in the
TRN due to the complexity of TF regulation. There are thus
compositional overlaps in the membership of biological modules.
We designed a novel comprehensive clustering algorithm
(Figure 2; see MATERIALS AND METHODS) as an improve-
ment to non-overlapping clustering strategies to retrieve overlap-
ping co-expression gene modules. Systematic optimization was
used in this clustering approach for selecting the most likely
coregulated genes from several sets of co-expression gene modules.
We defined the optimal set of co-expression gene modules as the
set of modules that obtained the best configuration of those
modules in the genomic scope as evaluated by the Davis-Bouldin
Index (DB Index). This best configuration of modules is a best
approximation of biological co-expression gene modules given the
selected data [18,19].
We applied this strategy of comprehensive clustering to generate
a plot of DB Indices throughout the computed top sets (Figure 3)
of co-expression gene modules. The DB Index for the top set
where N=520 was the minimum computed DB Index (4.9047),
which corresponds to the best configuration of modules. We found
around 34.6% genes have more than one modular membership
within the set. The optimal set of 765 co-expression gene modules
that we computed for the mouse cardiac development dataset are
listed in Table S2. All 15711 selected gene features were included
in the 765 co-expression gene modules. The maximal re-
occurrence of a gene in different modules is 8, and the mean
occurrence of genes in different modules is 1.49. We compared
this improved clustering algorithm with other overlapping
clustering algorithms: fuzzy clustering and biclustering. We set
the cluster number to 765 for the other clustering algorithms to
obtain respective sets of co-expression gene modules from the
cardiac development microarray sets. We applied gene ontology
term enrichment tests (molecular function category only) to
identify the enriched molecular functions in each set where the
ratio of modules having at least one term enriched out of all the
modules is the metric used to make the comparison [28]. We
found the improved clustering (272/765) and fuzzy clustering
(271/765) shared similar degree of annotated modules in their
respective sets, while biclustering resulted with very few modules
when we set the parameter related to cluster number to 765 and
none of them was annotated by any enriched term. Therefore, we
can conclude that our improved clustering outperforms bicluster-
ing, and it performs as good as fuzzy clustering when parameters
for fuzzy clustering are chosen appropriately (e.g. fuzziness and
memberships for each observation/gene).
Phase specific expression activity in inferred modules for
mouse cardiac development
We analyzed expression profiles for the co-expression gene
modules during the period of prenatal cardiac development
(E10.5,E18.5) using the arrays in the dataset that were associated
with these distinct phases of development (GSE1479). In order to
inspect whether there is differential expression among the phases
in the modules, we first grouped the arrays based on the seven
phases: E10.5, E11.5, E12.5, E13.5, E14.5, E16.5 and E18.5. We
then graphed the expression trace of each module in the
developmental time order of the seven phases. For each module,
we compared the expression among phases to identify the phase
specific expression within the module.
Figure 1. Molecular interaction network results from the literature-based Cognoscente knowledgebase where several genes with
important roles in cardiac development were queried: Nkx2-5, Gata4, Gata5, Tbx1, Tbx5, Pitx2 and MEF2c (red boxes). Red arrows
point from the TFs (proteins) to their targets (DNA), black solid lines represent protein-protein interactions and red dashed lines represent genetic
interactions. Stacked boxes (which sometimes repeat the same gene name) in the figure show orthologs of genes in organisms where the ortholog
has a documented interaction. Node colors indicate different model organisms as defined in the Taxa Key. Here, one example of the complicated
transcriptional regulation is that Foxh1 transcription factor physically and functionally interacts with Nkx2-5 transcription factor to regulate the
expression of Mef2c gene (inset region).
doi:10.1371/journal.pone.0083364.g001
Table 1. Signature genes expressed in mouse during cardiac development.
Cardiac Crescent Linear Heart Chamber Formation Maturation/Septation
Gata4 Gata4 Gata4 Gata4
Nkx2-5 Gata5 Nkx2-5 Nkx2-5
Mesp1/2 Tbx5 Tbx5
dHand RxRa
eHand FOG-2
Pitx2 Pitx2
MEF2C Sox4
NF-Atc
TEF-1
Tbx1
Hey2
CITED
ZIC3
Cardiac development follows a procession of the following four stages: cardiac crescent, linear heart, chamber formation and finally maturation/septation. Gene
functions during cardiac development are generally described in terms of these four milestones [5].
doi:10.1371/journal.pone.0083364.t001
Transcriptional Regulation in Heart Development
PLOS ONE | www.plosone.org 4 January 2014 | Volume 9 | Issue 1 | e83364
Figure 2. Computational strategy of our comprehensive clustering approach. 239 selected arrays for distinct phases of mouse cardiac
development were used as source transcriptomic data. In step 1, for each iteration (N=N0:u:Nmax) a cumulative set of modules is constructed using k-
means clustering of the current iteration (k=N, circle represents a module, where circles of the same color are from one instance of k-means
clustering) and this instance is combined with the cumulative set of modules from the previous iteration (cumulative set 1, cumulative set 2, …
cumulative set x). In step 2, the top set from each of the cumulative sets is created by selecting the modules corresponding to the top robustness
scores to cover all the genes on the array (top set 1, top set 2, … top set x). The Davis-Bouldin Index (DB Index) of every top set is calculated to
measure modular configuration in the set (DB Index 1, DB Index 2, … DB Index x). In step 3, the minimal calculated DB Index describes the best
modular configuration and corresponds to the optimal set of co-expression gene modules. (see details in METHODS).
doi:10.1371/journal.pone.0083364.g002
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Figure 4 shows differential expression in phases for sampled
modules. Modules in group 1 have the highest level of expression
at E10.5; modules in group 2 have the highest level of expression
at E11.5; modules in group 3 have the largest level of expression at
E16.5 and the modules in group 4 have the highest level of
expression at E18.5. We analyzed the whole optimal set of
modules and found that (1) 55.4% modules have significantly
different expression (FDR adjusted p,0.05) among the phases; (2)
46% modules have significantly different expression (FDR
adjusted p,0.05) between E10.5 and the other phases; (3)
33.2% modules have significantly different ial expression (FDR
adjusted p,0.05) between E11.5 and the other phases; (4) 16.1%
modules have significantly different expression (FDR adjusted
p,0.05) between E16.5 and the other phases; (5) 35.9% modules
have significantly different expression (FDR adjusted p,0.05)
between E18.5 and the other phases (Table S3). We assigned
each of the modules to pattern groups corresponding to their
phase specific expression.
Module phase categories were assigned in the table of
differential expression analysis (Table S3) and module assign-
ments were summarized according to the phase specificity of gene
expression in the modules (Figure 5): category P_non (includes
modules having no significantly different expression among
phases), category P10.5 (includes modules having the significantly
largest level of expression at E10.5), category P11.5 (includes
modules having their significantly highest level of expression at
E11.5), category P12.5 (including modules having their signifi-
cantly highest level of expression at E12.5), category P13.5
(includes modules having their significantly highest level of
expression at E13.5), category P14.5 (includes modules having
their significantly highest level of expression at E14.5), category
P16.5 (includes modules having their significantly highest level of
expression at E16.5) and category P18.5 (includes modules having
the ir significantly highest level of expression at E18.5).
Known molecular pathways formalize the developmental
program in mouse heart
The symphony of life is performed by numerous molecular
reactions in an interconnected network. The great abundance of
new high-content experimental data is fueling an understanding of
molecular pathways with the formalized composition of intercon-
necting reactions. Wikipathways provides an open and collabora-
tive platform dedicated to the curation of experimentally-
supported biological pathways [29,30]. In order to inspect the
known molecular pathways implementation in the developmental
program of mouse heart, we developed a strategy leveraging the
Wikipathways knowledgebase to estimate the overrepresentation
of known mouse molecular pathways throughout our optimal set
of co-expression gene modules (Figure 6; see MATERIALS AND
METHODS).
We obtained 161 well-known mouse molecular pathways from
the Wikipathways knowledgebase. For each module from the
optimal set for mouse cardiac development, we applied enrich-
ment tests to inspect the overrepresentation of the known
pathways in the module. We thus obtained a table of pathway
overrepresentations (FDR adjusted p,0.05) from systematic
enrichment tests (Table S4). Overrepresented pathways may
have central roles in the developmental program of mouse heart.
As every module was assigned to one phase category according
to the highest level of modular expression in that phase, the
overrepresented pathways in a category are highly expressed in the
corresponding phase. Figure 7 shows the most frequently
overrepresented pathways (top 25) in P10.5 (A) and P18.5 (B),
where module members are highly expressed at E10.5 and E18.5,
respectively. In the phase of E10.5, pluripotency-related pathways
are highly expressed; while in the phase of E18.5, metabolism-
related pathways are highly expressed. The two featured series of
pathways fit well with their respective phases of early development
and late development in mouse heart. In addition, we found the
Wnt, TGF-beta and EGFR1 signaling pathways were highly
expressed in the phase of E10.5. The interferon, TNF-alpha, NF-
kB, B cell receptor, inflammatory response, Toll-like receptor, IL1,
IL4, IL5 and IL6 signaling pathways are highly expressed in the
phase of E18.5. We also found that the two phases shared one
highly expressed pathway: MicroRNAs in cardiomyocyte hyper-
trophy. These pathways are highly expressed to mediate the
respective phase transitions of mouse cardiac development.
Transcriptional regulations driving the developmental
program of mouse heart
JASPAR is a curated database that collects known Transcrip-
tion Factor Binding Site (TFBS) motifs in various organisms from
the experiment-based literature [31]. We selected mouse-specific
TFBS motifs and mouse-homologous TFBS motifs as the baits in a
promoter pool (promoters were obtained from MPromDb and the
UCSC Genome Browser) of every co-expression gene module
from the optimal set for mouse cardiac development to identify
possible TFBSs on the modular gene promoters via sequence
alignment tests. Once we identified the possible TFBSs, we
inferred the possible transcriptional regulations between the
corresponding TFs and the module. However, alignments can
arise from random sequence variation that produces false positive
hits of TFBS motifs on the gene promoters. We therefore applied
TFBS enrichment tests to each module to exclude the false-
positive cases in our prediction of transcriptional regulations for
each module (Figure 6, see details in MATERIALS AND
METHODS).
Figure 3. DB Index as a function of N. N is the number of
iterations of comprehensive clustering used specify each top
set of co-expression gene modules. The arrow marks the lowest
calculated DB Index of 4.9, where N= 520. Lower DB Index values
correspond to better configuration, so the top set of clusters for N = 520
is the optimal set of co-expression gene modules.
doi:10.1371/journal.pone.0083364.g003
Transcriptional Regulation in Heart Development
PLOS ONE | www.plosone.org 6 January 2014 | Volume 9 | Issue 1 | e83364
We obtained 160 known TFBS motifs (mouse-specific and
mouse-homologous) from JASPAR. For each module from the
optimal set for mouse cardiac development, we applied enrich-
ment tests to inspect the overrepresentation of the known TFBS
motifs in this module. We compiled a table of TFBS motif
overrepresentation (FDR adjusted p,0.05) from these systematic
enrichment tests to infer the putative transcriptional regulations of
the modules (Table S5). The predicted transcriptional regulations
are the basic components of our provisional TRN of mouse
cardiac development.
TFs corresponding to the overrepresented TFBS motifs in a
category are likely to be responsible for the increased expression in
the corresponding phase. Figure 8 shows the TFs that correspond
to the most frequently overrepresented TFBS motifs (top 15 from
mouse, human and rat) that have a Pearson correlation .=0.3
with module expression in categories: P10.5 (A), P11.5 (B) and
P18.5 (C). Expression of modules in these phases is thus likely
mediated by TFs for the respective overrepresented TFBS. In the
phases of E10.5, E11.5 and E18.5, which denote the early and late
heart development, several TFs such as Sox5, Sox9 and Prrx2, are
shared as the top-ranked lists of TFs across these developmental
phases. There are also TFs in the list of top-ranking overrepre-
sented TFBSs that are uniquely enriched in distinct phases. For
example, Gata2, Nkx3-2 and Mef2a are enriched in E10.5
modules, Gata3, Stat3 and Jun in of E11.5 modules, Brca1 and
Stat1 in E18.5 modules. Taken together, TFs work together both
across phases and in a phase-specific manner to regulate phase
specific expression and mediate phase transitions during normal
cardiac development.
We integrated the table of pathway overrepresentation with the
table of TFBS motif overrepresentation to assign the TFs
Figure 4. Heatmap of expression profiles across the cardiac developmental phases (E10.5–E18.5) for sampled modules. The modules
in group 1 (G1) have the highest level of expression at E10.5; the modules in group 2 (G2) have the highest level of expression at E11.5; the modules
in group 3 (G3) have the highest level of expression at E16.5; the modules in group 4 (G4) have the highest level of expression at E18.5.
doi:10.1371/journal.pone.0083364.g004
Figure 5. The optimal module set was classified into eight
categories according to the phase specific expression in the
modules. The table and bar plots summarize the classifications.
doi:10.1371/journal.pone.0083364.g005
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corresponding to those TFBS motifs with pathway annotations,
thus providing clues for TF involvement in known molecular
signaling pathways for mouse cardiac development (Table S6).
A provisional transcriptional regulatory atlas of mouse
cardiac development
To develop a network structure conveying the transcriptional
regulations of mouse cardiac development in the genome-wide
scope, the TRN was represented using the Graphviz network
drawing tool to present the transcriptional regulations inferred in
the previous section. TF-gene regulations were established by
assigning every inferred TF-module regulation to each gene
member of the module. We distinguish between two types of TF-
gene regulations: TFBS-aligned regulations where a specific TFBS
is found on the regulated gene promoter and TFBS-non-aligned
regulation where the specific TFBS is not found on the regulated
gene promoter (Table S7). There are several possible explana-
tions for the TFBS non-aligned regulations, including incomplete
information of the TFBS motifs. We examined the inferred
transcriptional regulations and identified a recurring pattern
whereby multiple TFs in the same module regulate individual
genes in another module. In these cases, target genes had similar
expression profiles because their respective TF regulators had
similar expression profiles (Figure 9B). In these examples, non-
aligned targets may be thought of as indirect or incidental
regulatory targets. Because of the evident likelihood that non-
aligned targets were indirect targets, we only used TFBS-aligned
regulations as transcriptional regulations in the assembly of the
provisional TRN of mouse heart development. To summarize the
provisional TRN, we assembled the core network of regulations
between sampled mouse transcription factors (Figure 9A). As the
core of the TRN, the transcriptional regulations among sampled
TFs formed a sub-network where the number of edges is ten-fold
greater than the number of nodes. This graph lifts a corner of the
complexity in the TRN of mouse cardiac development.
Transcriptional regulation of a target gene is the collaborative
work among several TFs, co-activators and co-repressors. There-
fore we integrated a compendium of documented knowledge of
TF protein – TF protein interactions with the inferred transcrip-
tional regulations to define the TRN of mouse cardiac develop-
ment [32] Table S8: TF regulatory complex of 2 TFs; Table S9:
TF regulatory complex of 3 TFs). These combinatorial regulations
are well supported by evidence that the target gene is regulated by
multiple interacting TFs. Gata1 and SFPI1 are well-studied
examples having a physical interaction, and are found in our
provisional TRN to co-regulate AT1B in a co-expression gene
module that doesn’t show differential expression across develop-
mental phases (Figure 9C). Our result is consistent with AT1B
being previously defined to play key role in mouse normal cardiac
morphology [33]. GFI1, TCF3 and BRCA1are the well-studied in
development and cancer. From the provisional TRN, we infer that
these TFs co-regulate ErbB4 (Figure 9D). This novel complex
regulation was retrieved in a co-expression gene module that has
its significantly highest level of expression at E18.5. We note that
not every documented TF – TF interaction was successfully
incorporated with the inferred regulations to offer a complete
description of combinatorial regulation of gene transcription.
Coverage of the array platform used in the definition of gene
modules is incomplete, and we posit that the context of heart
lineage development is central to our findings, so we expect that
gene regulations specific to other contexts will not be identified
with the dataset employed here. To summarize the TRN at the
modular scope, we graphed modules so that node diameter is
proportional to the log10 of module size (number of genes in
module), node color corresponded to phase category (as measured
by phase specific expression), and directed edges were drawn
between modules containing transcription factors and those
modules containing their respective inferred targets (Figure 10).
Figure 6. Flow chart summarizing further analysis after computing the optimal set of co-expression gene modules. We applied the
hypergeometric enrichment test to each module to inspect the overrepresentation of known pathways central to mouse cardiac development. In
parallel, hypergeometric enrichment tests were performed for transcription factor binding sites (TFBS) in modules to obtain the overrepresented/
enriched TFBSs and infer the corresponding transcriptional regulations comprising the TRN in the mouse cardiac developmental program. Finally, the
ENCODE associated transcriptional regulations were used as a reference set to test the performance of our strategy for inferring the TRN.
doi:10.1371/journal.pone.0083364.g006
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Evaluation of the provisional transcriptional regulatory
network using the ENCODE database
The ENCODE database offers source data from large-scale
ChIP-seq experiments of selected TFs to identify the correspond-
ing DNA binding sites in mouse genome [34]. We obtained data of
genomic binding sites for several TFs (Usf1, Tcf3, Tbp, Tal1, Srf,
Pax5, Nrf2, Max, Gata2, Gata1, Ets1, Ctcf, Cmyc, Cjun) from the
ENCODE database to evaluate the inferred transcriptional
regulations of those TFs in our provisional TRN of mouse cardiac
development. Based on the ChIP-seq data, the regulated gene pool
of every sampled TF was estimated from the analysis for the
location associations between its genomic binding sites and the
Figure 7. Overrepresented pathways for P10.5 and P18.5. A. The top 25 overrepresented pathways in P10.5, where modules in this class have
their highest level of expression at E10.5. Pathways in red boxes are pluripotency-related pathways enriched in P10.5 modules; pathways highlighted
in yellow are also enriched in P18.5. B. The top 25 overrepresented pathways in P18.5, where modules in this class have their highest level of
expression at E18.5. Pathways in blue boxes are metabolism-related pathways enriched in P18.5 modules; pathways highlighted in yellow are also
enriched in P10.5.
doi:10.1371/journal.pone.0083364.g007
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gene promoters. The metric used in the evaluation is the ratio of
the number of the inferred transcriptional regulations for a specific
TF found in the regulated gene pool based on the ChIP-seq data
for this TF (regulations in agreement) to the number of all the
inferred transcriptional regulations (regulations inferred from
enrichment tests) for this TF (Table 2).
This ratio varies across the sampled TFs. ENCODE projects
were performed on specific cell lines and for specific experimental
conditions. Unfortunately, relatively few ENCODE samples are
relevant to cardiac development. Access to TF binding sites on the
genome is dynamic across diverse cell or tissue types [35].
Therefore, computing this ratio gives a sense of the concordance of
ENCODE results and our inferences, but is not able to completely
evaluate the inferred transcriptional regulations of the sampled
TFs in cardiac development. However, the agreements between
the predicted regulations in the TRN and the regulations obtained
from ChIP-seq data in the ENCODE database support the
analytical power of our novel algorithm for inferring several
transcriptional regulations that were also inferred by another
completely different analysis. We also show that ChIP-seq data for
different cell types or different conditions have reasonably good
agreement. Therefore, by obtaining additional ChIP-seq data of a
sampled TF for heart lineage samples in the future, we expect that
the ratio may become a more reliable metric to evaluate
inferences.
Discussion
Our novel algorithm to retrieve the optimal set of co-expression
gene modules in the genomic scope from a large selection of
microarray data associated with mouse cardiac development
allows overlap among the modules to maximally approximate
biological co-expression gene modules. Differential expression
among phases in the modules was identified. We applied the
hypergeometric enrichment test to identify overrepresented
pathways of the modules to infer important pathways involved
in the developmental program of mouse heart. These pathways
thus provide important clues for understanding the mechanisms
underlying the phase transitions during cardiac development. In
order to infer the provisional TRN of mouse cardiac development,
we applied the hypergeometric enrichment test to find true-
positive transcriptional regulations for each module by identifying
overrepresented TFBSs in the module. We further integrated
documented TF protein – TF protein interactions with the
inferred transcriptional regulations to include TF combinatorial
regulation in the TRN of mouse cardiac development. Gata1 and
SFPI1 were found in the TRN to co-regulate AT1B. GFI1, TCF3
and BRCA1 were found to co-regulate ErbB4. In addition, we
used the obtained ChIP-seq data of genomic binding sites from the
ENCODE database for the sampled TFs to evaluate the inference
of the TRN. The agreements between the inferred regulations in
the TRN and the regulations obtained from ChIP-seq data imply
the inferential power of the novel algorithm.
With the fast development of the next generation sequencing
(NGS), RNA-seq may become the mainstream technology for
generating transcriptomic data based on improved accuracy and
the capacity of detecting novel transcripts. Using better source
transcriptomic data in our algorithm will infer the TRN with
closer approximation to the biological TRN. DNA-seq is
developing fast with the evolution of NGS. The genomic binding
sites of sampled TFs from DNA-seq can be integrated with
transcriptomic data by our algorithm to infer transcriptional
regulations. However, due to the unavailability of molecular
probes for many TFs, it will remain a challenge to infer TRNs at
Figure 8. The top 15 TFs (mouse, human or rat) corresponding
to the most frequently overrepresented TFBS motifs having a
Pearson correlation .=0.3 with module expression in phase
categories. P10.5 (A), P11.5 (B) and P18.5 (C). Blue bars represent
frequency of TFBS motif overrepresentation (left axis); red dots show
the Pearson correlation of expression (right axis).
doi:10.1371/journal.pone.0083364.g008
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Figure 9. Partial visualization of the TRN for mouse cardiac development. A. Sub-network structure of the TRN, focusing on the sampled
TFs only. Nodes and their respective outgoing arrows are colored to help clarify arrow paths. B. An explanatory example showing TFBS non-aligned
transcriptional regulations. Foxd3 and Sox2 are in a co-expression gene module (beige box) and their individual TFBS aligned gene targets Tbr1 and
Syt4 are in another co-expression gene module (light blue box). As shown, Syt4 is TFBS non-aligned gene target for Foxd3 and Tbr1 is the TFBS non-
aligned gene target for Sox2, as Foxd3 and Sox2 are inferred TFs regulating Tbr1-Syt4 modular transcription. More complex scenarios for explaining
co-regulation for non-aligned TFBS motifs are possible. C and D show combinatorial transcriptional regulations in the TRN inferred from the
integration of the inferred transcriptional regulations with documented TF protein – TF protein interactions.
doi:10.1371/journal.pone.0083364.g009
Transcriptional Regulation in Heart Development
PLOS ONE | www.plosone.org 11 January 2014 | Volume 9 | Issue 1 | e83364
the genomic scope. In addition to the genetic regulation,
epigenetic regulation is an important contributor to transcriptional
regulation [36]. One future direction for this work is to integrate
the inferred TRN with known epigenetic regulations to define
important connections between genetic and epigenetic regulation
in cardiac development.
A disease is rarely a consequence of an abnormality in a single
gene but rather the consequence of a sustained perturbation in a
complex network of molecular interactions. Therefore, identifying
the perturbed sub-network in a specific disease process will provide
opportunities for improved diagnoses and more effective therapies.
We speculate that in the near future the integration of omics data
from a patient, including genome sequence and transcriptome
analysis, together with an accurate TRN of heart development will
provide a strong basis for indicating the status network perturba-
tions, and greatly assist the diagnosis and the formation of a
personalized therapeutic strategy for CHD. Defined disease
modules can be applied as network-based biomarkers for
diagnosis. A recent example illustrates this potential with the
identification of network-based biomarkers for classifying breast
cancer metastasis [37]. Network-based medicine is a promising
Figure 10. Provisional atlas of TRN modules for cardiac lineage development. Nodes are labeled with module index numbers. Node
diameter is proportional to the log10 of the number of genes in each module, node color corresponds to phase class as shown in the legend, and
directed edges (same color as the module they point from) represent transcriptional regulation between modules.
doi:10.1371/journal.pone.0083364.g010
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concept for innovative diagnostic approaches and therapeutic
strategies [38].
Materials and Methods
Microarray dataset
Public domain microarray data used in this study covered
important temporal phases of cardiogenesis for elucidating the
transcriptional landscapes active during mouse cardiac develop-
ment. Array descriptions (15711 selected gene features) are in
Table S10. We used the Robust Multi-array Average (RMA)
algorithm to normalize the 239 microarrays, which were
experiments all performed on the Affymetrix Mouse Genome
430 2.0 Array platform (GEO accession: GPL1261) [39].
Comprehensive clustering algorithm
The algorithm of comprehensive clustering: N was defined as
the number of the newly generated candidate modules in one
iteration of the algorithm such that N=N0: u: Nmax, where N was
the number of modules (N= k) to form using k-means clustering, N0
was the initial (smallest) number of modules to start with, and u
was the size of an incremental increase per iteration, up to Nmax.
The distance measure for k-means clustering was 1-r, which was
one minus the correlation of the expression profiles between genes.
The expression profiles of genes in the module were centered and
normalized to calculate the component-wise mean of them as the
centroid. N was increased incrementally by u to Nmax, or until a
single-gene module occurs (natural stopping condition). The
cumulative set of co-expression gene modules for a given N was
defined as the aggregation of co-expression gene modules from k-
means clustering for k=N together with the cumulative set of co-
expression gene modules formed for (N-u) that contained all the co-
expression gene modules from multiple rounds of k-means
clustering for k=N0 to k= (N-u) with the incremental increase of
u per round. Thus after several iterations, we obtained several
cumulative sets of co-expression gene modules and each set was
labeled with its corresponding N. Generally, co-expression gene
modules newly retrieved in the iteration with larger k of clustering
are more robust. We defined robustness score of each such module
in a cumulative set by the probability of its existence in the
iterations of k-means clustering that contribute to this cumulative
set. ‘Existence’ is based on the criterion that a module’s genes are
all represented together in a module, although this single module
may have other members. The more frequently the genes of a
module all appear together in other modules, the higher its
robustness score will be. We then sorted all the modular robustness
scores in the cumulative set labeled by its specific N to retrieve the
top co-expression gene modules by ordering robustness scores
from large to small until we obtain complete coverage of all genes
on the array. These ordered modules are collectively called the
‘top set’ of co-expression gene modules for the given N. We thus
obtained several top sets corresponding to the cumulative sets. In
order to identify the optimal configuration of co-expression gene
modules among those several top sets, we examined each set with
the DB (Davies-Bouldin) Index to calculate the overall goodness of
the overlapping modular configuration in this set (where the top
set of co-expression gene modules satisfied the overlap condition).
The optimal set of co-expression gene modules among the top sets
was determined by identifying the top set with the minimal DB
Index, which indicated the optimal configuration of modules in the
set.
IDB~
1
k
Xk
j~1
max
j=l
WDB(j)zWDB(l)
BDB(j,l)
 
ð1Þ
DB Index: k is the total number of modules; WDB(j or l) is the
intra-module compactness for module j or module l, respectively;
and BDB(j, l) is the separation between module j and module l
(Figure 11).
A gene’s transcription is regulated by a combinatorial group of
TFs [32]. Each TF group can regulate several genes as
demonstrated by co-expression gene module members that
cooperatively accomplish specific biological functions [18]. Each
of hundreds of TFs has several co-association TF subsets (size of
the subset generally ranges from 2 to 5) based on genomic binding
overlaps from ChIP-seq experiments [40]. Therefore hundreds (or
Table 2. Summary of the agreements between the inferred transcriptional regulations and the regulations obtained from ChIP-
seq data in the ENCODE database for several sampled TFs.
TF Regulations in agreement Regulations inferred from enrichment tests Ratio
Usf1 38 220 0.17
Tcf3 160 2867 0.06
Tbp 1492 3807 0.39
Tal1 78 126 0.62
Srf 0 2 0
Pax5 0 127 0
Nrf2 0 22 0
Max 5 32 0.16
Gata2 419 3736 0.11
Gata1 3049 4102 0.74
Ets1 289 467 0.62
Ctcf 7 8 0.88
Cmyc 40 132 0.30
Cjun 973 3041 0.32
doi:10.1371/journal.pone.0083364.t002
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greater) of TF combinatorial groups are possible in a given
physiological/pathological process. Accordingly, hundreds of their
corresponding co-expression gene modules are possible. We
therefore assigned N0 with 100 as the initial smallest value to
consider for k-means clustering. Starting with the obtained
modules from the k-means clustering of k and from the k-means
clustering of (k+10), every gene was assigned into two modules, one
module from the clustering of k and the other module from the
clustering of (k+10), and between the two modules we found that
on average (k was assigned incrementally) genes grouped together
with at least one of the same gene neighbors in 80% of the total
tested genes. This demonstrated good robustness of modular
membership of genes between the clustering and the subsequent
clustering when the increment u was set to 10. We then set the
increment u to 10 for subsequent iterations of the comprehensive
clustering algorithm. As we performed comprehensive clustering
with overlap [18], we specified the top set of co-expression gene
modules with overlap rate .=1% as the qualified set.
Analysis of the differential modular expression
throughout developmental phases
Samples were assigned to phases as described in Table S10.
We used ANOVA to test the differential expression in the module
among the phases. The False Discovery Rate (FDR) was applied
for multiple test correction. To test the differential expression in
the module between one phase and the others, we applied t-tests to
modular expression data and FDR was applied for multiple test
correction.
Enrichment tests
In order to identify the TFs that drive co-expression in a defined
gene module, we inspected the known TFBS motifs on the gene
promoters of this module. However, matching hits of known TFBS
motifs on gene promoters can be spurious false positive hits. We
evaluated the matching hits of TFBS motifs in a module against a
hypergeometric distribution to exclude the cases of random motif
matches in the module. The hypergeometric function describes the
probability of exactly k successes in n draws from a finite
population size T where the number of successes in the whole
population is m.
P(X~k)~
m
k
 
T{m
n{k
 
T
n
  ð2Þ
By letting k = integers k through n, the hypergeometric
probabilities may be summed to find P(X.= k), and obtain the
probability of the proposition that the number of successes
observed or a higher number of successes in n draws would occur
by chance. If this is less than 0.05 (a typical choice), we
demonstrate that the situation of k successes in n draws is
significantly unlikely due to chance. Thus, the attribute corre-
sponding to the success is defined to be overrepresented in the n
draws against the background of m successes in T population. In
the case of evaluating the hits of the known TFBS motif onto the
gene promoters in a module, this approach is specified as the
Figure 11. Algorithm for comprehensive clustering.
doi:10.1371/journal.pone.0083364.g011
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TFBS motif enrichment test. In our study, for any known TFBS
motif, k was the number of gene promoters that had the binding
site of this TFBS motif in the co-expression gene module being
tested, n was the number of genes in this module and m was the
number of gene promoters that had the binding site of this TFBS
motif in the tested genome and T was the number of genes in the
tested genome. Via referring the overrepresented/enriched TFBS
motifs to their corresponding TFs, we inferred their transcriptional
relations in each module.
The hypergeometric test was also used for the pathway
enrichment tests in this study. For any pathway, k was the number
of genes or gene products which had functional positions in a given
pathway from the co-expression gene module being tested, n was
the number of genes in this module, m was the number of genes or
gene products that had functional positions in the complete
pathway and T was the number of genes in the tested genome.
Overrepresentation was assessed when k.1 for a given TFBS
motif or pathway.
Databases
MPromDb (Mammalian Promoter Database) is a curated
database that annotates gene promoters identified with ChIP-seq
which is one of the most robust approaches of defining gene
promoters [41]. The ChIP-seq data sets of RNAP-II and various
TFs were included in significance tests to retrieve the gene
promoters archived in this database. To complete retrieving the
gene promoters in the genomic scope, gene promoters (from
5000 bp upstream the TSS to 1000 bp downstream the TSS) that
are not covered by MPromDb were retrieved from UCSC genome
browser [42].
JASPAR is a curated database of known TFBS motifs for
various organisms from the experiment-based literature [31], and
was used in this study to identify motif matches in the promoters of
module genes. TFBS motifs are stored as a position weighted
matrix (PWM) in JASPAR.
TRANSFAC is a curated database of eukaryotic transcription
factors, and includes experimentally-proven binding sites and
regulated gene targets [11,12]. Publicly available TRANSFAC
knowledge was summarized in Figure S1.
Wikipathways is an open, collaborative platform dedicated to
the curation of biological pathways, in order to facilitate the
contribution and maintenance of the pathway information
[29,30]. The Wikipathways knowledgebase was used in this study
as the basis for evaluating pathway overrepresentation in the
defined co-expression modules.
We collected the ChIP-seq data for the sampled TFs of mouse
from Encode database (Experiment details for the sampled TFs
can be found in Table S11). ChIP-seq data reveal genomic
binding sites for TFs. The regulated gene pool of every sampled
TF was estimated from an analysis of proximity between genomic
binding sites from ChIP-seq and the gene promoters.
TFBS motif alignment
TFBS is a motif alignment program that was obtained from
JASPAR (http://tfbs.genereg.net/). It is able to align the TFBS
motif onto the gene promoters either in the co-expression gene
module or in the genome. In this program, within one promoter
sequence, the PWM of one TFBS motif slides over the sequence in
1-bp increment, and each potential binding site is evaluated
against the PWM on both strands through a quantitative score.
The quantitative score for a potential binding site of a specific
TFBS motif is produced by summing the relevant nucleotide
PWM values, analogous to the probability of observing this
potential binding site given the source of this TFBS motif [43].
Then we defined the hits of the TFBS motif on the promoter with
the quantitative scores above the corresponding threshold as the
predicted binding sites that contribute to k or m in the TFBS motif
enrichment test.
Data access
Results are available in the Supporting Tables. In-house
software used to conduct this investigation is available upon
request. The normalized expression dataset is available in a
compressed archive (Dataset S1).
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